• Epidemiology, quality and reporting characteristics of systematic reviews of acupuncture interventions published in Chinese journals
• Epidemiology, quality and reporting characteristics of systematic reviews of CT orMRI diagnostic test accuracy published in Chinese journals
• Epidemiology, quality and reporting characteristics of systematic reviews on TCM published in China journals
• Epidemiology, reporting characteristics and PRISMA-NMA adherence of systematic reviews with network meta-analysis: a meta-research study
• EPIMETA: software for meta analyses of epidemiologic studies
• Epistemonikos Database of Randomized Trials: methods and preliminary results of a comprehensive, living database of trials
• Epistemonikos is building a ‘one-stop shop’ of synthesized nutrition evidence and LOVES to enable rapid-learning and decision-making to reduce malnutrition
• Epistemonikos is leading a multi-country, multi-disciplinary collaboration to build a multi-lingual ‘one-stop shop’ of synthesized nutrition evidence
• Epistemonikos: a comprehensive, systematic, collaborative and multilingual database for evidence-based health care
• Epistemonikos: a comprehensive, systematic, collaborative and multilingual database for evidence-based health care
• Epistemonikos: a comprehensive, systematic, collaborative and multilingual database for evidence-based health care
• EPOC activities and Australian health policy
• EPPI-Reviewer 4 practical: advanced session
• EPPI-Reviewer: an online tool for conducting complex reviews
• EPPI-Reviewer: review-production software that adapts to your needs
• EPPI-Reviewer: Review-production software that adapts to your own needs
• EPPI-Reviewer: review-production software that adapts to your own needs
• Equalization of basic public health services policy in China and its impacts on inequalities in services coverage
• EQUATOR Network workshop. Reporting guidelines: An effective tool to improve reporting of research studies and other reports
• Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases
• Equity considerations in the conduct of evidence syntheses in partnership with patients and other stakeholders
• Equity in the development of COVID-19 formal recommendations and good practice statements
• Equity reviews: challenges, opportunities and next steps
• eRegistries: Dissemination of healthcare guidelines to frontline providers
• EROS dialogues with RevMan: data extraction, quality assessment and more ***in computer lab; no need for personal laptops
• EROS: web-based software for the initial phases of a systematic review
• Error identification in search strategies of new Cochrane Reviews published in 2015
• Essential core competencies for health policy doctoral graduates
• Essential items in reporting diagnostic accuracy studies: 2015 update of the STARD Statement
• Establishing a Cochrane roadmap to data models for asking relevant clinical questions and finding the best answers individually for each patient
• Establishing a database of RCT, CCT and diagnostic tests in China
• Establishing a dedicated respository for Cochrane Colloquium proceedings and presentation materials
• Establishing a Glocalization Methodology for Developing and Updating Evidence-based Clinical Practice Guidelines: Taiwan experience.
• Establishing a special mechanism which aims to promote the whole level of study quality of clinical medicine in China
• Establishing and prioritising a local health research agenda with end users
• Establishing Chinese Clearinghouse for Evidence-Based Practice and Policy
• Establishing database of RCT reports published in Chinese with English citation and PICO to support Cochrane reviewers within the Collaboration
• Establishing the database of systematic review glossary
• Establishing the prevalence of low back pain in Africa: Methodological issues in putting it all together
• Establishing thresholds for important benefits in screening guidelines
• Establishments of the Cochrane India Network: Sharing initial experiences
• Estimating a test’s accuracy using tailored meta-analysis—the potential of setting-specific data in aiding study selection
• Estimating costs of lost productivity – examples of methodological shortcomings from an evaluation related to long-term sickness absence
• Estimating diagnostic accuracy when primary studies selectively report cut-offs: individual participant data meta-analysis versus three methods for analyzing published data
• Estimating hazard ratios using Parmar's methods
• Estimating risk differences and NNTs with adjustment for balanced covariates
• Estimating risk differences in patient-important events when studies have focused on surrogate outcomes: Application to systematic reviews and practice guidelines
• Estimating sample size in randomised controlled trials where patients are clustered
• Estimating the occurrence of non-standardised adverse outcomes: the case of lipodystrophy
• Estimating the parameters to a bivariate random-effects model in test accuracy meta-analysis using standard approaches
• Estimating the sample size of a clinical trial to make a meta-analysis conclusive. An example on meta-analysis of inhaled isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals
• Estimating treatment effects on patient-important outcomes from surrogate markers: the case of venous thrombosis
• Estrogens and osteoporosis: investigators concerned with technology rather than clinical science
• Estrogens and osteoporosis: quality of observational studies
• Estudantes para Melhores Evidências - a student-driven blog of Evidence-Based Healthcare content supported by Cochrane
• Ethical and practical challenges of big data in evidence-based health research: a scoping review
• Ethical review reporting of Chinese trials records in World Health Organization primary registries
• Ethics and the evidence in medical school education: melding outpatient medical ethics with training in evidence-based medicine
• Ethics of randomised controlled trials challenged: the selective cross-over in trials assessing efficacy of therapies for breast cancer patients
• ETIC and EMIC approaches to exploring concepts and experiences of psychological disorders
• EU EBM Unity Project: implementing systematic reviews into patient care through a unified European curriculum in evidence-based medicine
• European collaboration to identify reports of controlled trials in specialized health care journals in western europe
• Evaluating a suite of Cochrane HIV reviews
• Evaluating abstracts to predict low risk-of-bias RCTs using a natural language processing approach
• Evaluating both benefits and harms of interventions: the need for equality
• Evaluating Cochrane's centralised search and screening processes: a retrospective analysis of the Cochrane Central Register of Controlled Trial's (CENTRAL) coverage
• Evaluating cross-cultural adaptation and pooling of data from patient and clinician questionnaires in global clinical trials
• Evaluating diagnostic technologies: a review of strategies
• Evaluating Evidence Aid
• Evaluating evidence of radiation therapy in daily healthcare practices by developing a knowledge agenda – example from The Netherlands
• Evaluating external validity, applicability and transferability of evidence to primary care setting
• Evaluating heterogeneity in studies of diagnostic test accuracy
• Evaluating people’s ability to assess treatment claims: validation of a test in Mandarin developed from the Claim Evaluation Tools database
• Evaluating policies and programmes: An exploration of how the choice of non-randomised study design influences results
• Evaluating population-based interventions and translating evidence into action: overview of methods for the development of the guide to community preventive services
• Evaluating priority-setting approaches: tools for a Cochrane Methodology Review
• Evaluating risk of bias and applicability in individual participant data meta-analyses
• Evaluating risk of bias using prevalence-question systematic review as a model
• Evaluating the clinical credibility and implementability of clinical practice guideline recommendations using the AGREE-REX tool
• Evaluating the dissemination strategy for the Indian population with the outcome of two year’s disseminations on Tamil Translation of the Cochrane PLS.
• Evaluating the effectiveness of search strategies for systematic reviews in zoonotic public health
• Evaluating the feasibility of interventions for use within NHS mental health services
• Evaluating the impact of Cochrane Reviews
• Evaluating the impact of gender on performance of automated population identification from electronic health records
• Evaluating the impact of the Knowledge Broker Mentoring program on evidence-informed decision making using a qualitative approach
• Evaluating the impact of the national subscription to the Cochrane Library in India
• Evaluating the impact of the ViTaMIN (Virtual Training and Mentoring International Network) project
• Evaluating the quality of evidence and classification of intervention approaches for children with difficulties – two sources of unreliability
• Evaluating the transitivity assumption when constructing network meta-analyses: lumping or splitting?
• Evaluating three informal capacity building networks for systematic reviews
• Evaluating two statistical methods to predict when a meta-analysis will gain sufficient power to change the conclusions of a Cochrane review
• Evaluation and development of a novel interactive Summary of Findings table for network meta-analysis. A qualitative user-testing study with clinicians
• Evaluation of ‘spin’ in systematic reviews of diagnostic accuracy studies in high impact factor journals
• Evaluation of a novel citation-based search method vs. Ottawa/RAND Search Method for Prioritising systematic reviews for update
• Evaluation of a Plain Language Summary template for Cochrane Reviews
• Evaluation of a web-based interactive patient information (‘patient dialogue’) to enhance shared decision making
• Evaluation of a wiki-based platform to develop clinical practice guidelines
• Evaluation of AMSTAR to assess methodological quality of systematic reviews in overviews of reviews
• Evaluation of an organizational strategy for evidence-informed decision making
• Evaluation of baseline adherence to the PRISMA-DTA reporting guideline
• Evaluation of clinical guidelines for the management of end stage renal disease in Europe: the EU BIOMED 1 study
• Evaluation of Clinical Practice Guidelines Recommendations on the Screen and Management of Frailty
• Evaluation of clinical trials for Diabetes Mellitus in past 10 year to Chinese medical literatures
• Evaluation of COREL (Collaborative online Revman learning) an alternative training method of Cochrane systematic review process
• Evaluation of data-synthesis in systematic reviews of studies on outcome prediction models
• Evaluation of database contributions to a review on predictive analytics for disease progression: A SWAR using the R package CiteSource
• Evaluation of evidence-based practice skills of healthcare staff following educational workshops: a study protocol
• Evaluation of harms in HTAs and systematic reviews of drug interventions
• Evaluation of literature on the toxicity of Chinese herbal medicines
• Evaluation of network meta-analysis in clinical practice guidelines for percutaneous coronary intervention: A systematic review
• Evaluation of network meta-analysis in clinical practice guidelines for percutaneous coronary intervention: A systematic review
• Evaluation of novelty bias in multiple-treatments meta­regression within and between networks of comparison
• Evaluation of patient satisfaction using a clinical practice guideline for shoulder pain based on a leaflet in traditional Korean medicine: A randomised-controlled trial
• Evaluation of race, ethnicity, and income in systematic reviews used to develop drug formularies for state-provided healthcare
• Evaluation of risk of bias in non-randomized trial using the ROBINS-I tool: a pilot experience
• Evaluation of statistical heterogeneity measures and their precision in systematic reviews with meta-analysis and the impact in their interpretation
• Evaluation of the abstract screening tool Rayyan® in the context of the SBU Enquiry Service
• Evaluation of the consistency between network meta-analysis and standard pairwise meta-analysis: a meta-epidemiological study
• Evaluation of the efficacy of a prospective clinical trials register: the ISTH register
• Evaluation of the impact of evidence-based health care education for Chinese medicine practitioners
• Evaluation of the Impact of Grey Literature on Meta-Analysis.
• Evaluation of the Interim Cochrane Rapid Review Methods guidance – a mixed-methods study on the understanding of and adherence to the guidance
• Evaluation of the performance of five deduplication tools
• Evaluation of the priority ranking capabilities of SWIFT (Sciome Workbench for Interactive, Computer-Facilitated Text-mining) software
• Evaluation of the public health impact of Ixodes scapularis in Canada: A synthesis research approach
• Evaluation of the quality of Chinese diagnostic test accuracy studies in the imaging field using STARD 2015
• Evaluation of the quality of guidelines for gastric cancer with the AGREE II instrument
• Evaluation of the quality of prognosis studies in systematic reviews
• Evaluation of the search methods in systematic reviews related to climate change and adverse effects on health published in 2022-2023.
• Evaluation of the summary statistics used for meta-analyses using literature survival data oncology
• Evaluation of the treatment integrity as part of the risk of bias assessment. A proposal is needed
• Evaluation of utility of PubMed 'Article Types' filter for literature searching based on methodological quality
• Evidence about colchicine for gout to be added to 17th WHO EML
• Evidence Aid Lounge and the World Humanitarian Summit (WHS)
• Evidence Aid Resources: improving access to systematic reviews that are relevant to disasters
• Evidence Aid special collection for refugee health
• Evidence Aid Zika Collection
• Evidence Aid: Improving the science and evidence base of disaster response - a policy Delphi engagement
• Evidence and Gap Maps as a tool for research priority setting in India
• Evidence and gap maps to inform child welfare research priorities in Victoria, Australia
• Evidence and gap maps: A systematic approach to scoping
• Evidence and policy decisions in healthcare systems
• Evidence and recommendations: a systematic analysis based on 77 COVID-19 guidelines and consensus statements
• Evidence assessment on blood pressure management in spontaneous intracerebral hemorrhage: a scoping review
• Evidence based audit in oncology: analyses of three health plans in Brazil
• Evidence based evaluating and selecting essential medicine for Township Health Center located in the Eastern, Central and Western China—antihypertensive medicines
• Evidence based medicine and economics: a case study of a systematic review of dialysis management
• Evidence based medicine in the curriculum in medical schools in South East Asia
• Evidence based policy
• Evidence Based Practice Educational Program in Nursing Students' evidence-based practice Knowledge and skills: A Cluster Randomized Control Trial
• Evidence based practice workshop for senior managers in Ethiopia
• Evidence Based Practice: Is Nursing Research Ready for Partnership?
• Evidence Based Research Training School
• Evidence based sample size calculations for future trials based on meta-analyses
• Evidence based toolkits for enabling evidence use
• Evidence collection during disease outbreaks - Living systematic reviews
• Evidence ecosystem for knowledge translation in Nigeria: The bottlenecks and gaps to evidence uptake
• Evidence evaluation in ranking target areas of interest for a national patient safety campaign
• Evidence for different audiences about the medical use of cannabis and cannabinoids: a four-year experience in knowledge translation
• Evidence For evidence-based policy
• Evidence for health policy: bridging the gap between researchers and decision makers (perspective from the who regional office for Europe)
• Evidence for improving communication and participation: evaluation of Evidence Bulletin knowledge transfer
• Evidence for rare diseases is available, but poses challenges to synthesis: a case study
• Evidence for social and economic policy
• Evidence for the effectiveness of occupational health interventions
• Evidence from clinical trials is needed: what are Cuban medical journals doing about it?
• Evidence from health promotion/health education interventions: Relevance of developed world models to a middle income and developing country such as South Africa?
• Evidence from The Cochrane Collaboration for tradi­tional Chinese medicine therapies
• Evidence gap map on adolescent well-being in low- and middle- income countries: A focus on protection, participation and livelihoods
• Evidence gap maps – a tool for promoting evidence informed policy and prioritising future research
• Evidence gap maps (EGMs) and mapping reviews. An introduction to their purpose, methods and constructing an EGM
• Evidence gap maps for eye health: tool for promoting evidence and gaps in research
• Evidence gap maps: a tool for promoting evidence and gaps in low- and middle-income countries
• Evidence gap maps: a visual tool for promoting evidence and monitoring gaps in research
• Evidence gaps in health policy and systems research in 15 countries of the Eastern Mediterranean Region: a mapping exercise
• Evidence hesitancy in healthcare consumers in Cameroon in the treatment of uncomplicated malaria in children under five years of age
• Evidence implementation in low- and middle-income countries through the JBI Clinical Fellowship Program
• Evidence in social welfare: challenges and some possible solutions
• Evidence in the ‘‘instructions for authors’’ of surgical journals and their statistical requirements: a descriptive review of 70 leading surgical journals
• Evidence Informed Decision Making in Public Health: Lessons from a Journey to Build Organizational Capacity
• Evidence informed health policy, decision making for Rubella vaccine strategy in low and middle income countries: steps advocated
• Evidence into policy into practice: Showcasing the global Practical Approach to Care Kit (PACK) programme - session 1
• Evidence into policy into practice: Showcasing the global Practical Approach to Care Kit (PACK) programme - session 2
• Evidence mapping - do systematic reviews report the inclusion of women and sex as a moderator of intervention effects?
• Evidence mapping for decision making: feasibility versus accuracy – when to abandon high sensitivity in electronic searches
• Evidence mapping for youth mental health
• Evidence mapping of the decision-making process of a health insurance company in a middle-income country
• Evidence mapping of therapeutic interventions for Gastrointestinal Stromal Tumours (GIST)
• Evidence Mapping: Interventions to Lose Weight for Obese Population
• Evidence mapping: methodological foundations and application to epidemiologic research on sugar sweetened beverages and health
• Evidence mapping：a tool for synthesis and presentation of evidence
• Evidence Maps: A tool for stakeholder-engaged health-policy development
• Evidence matters: Examples of evidence-based decision making in humanitarian emergencies and how it can be improved
• Evidence meets the media: working with science journalists in South Africa
• Evidence of approved Chinese herbal medicines for treatment of type 2 diabetes in China
• Evidence of design-related bias among studies validating clinical prediction rule: a meta-epidemiological study
• Evidence of evidence in clinical practice: silver anniversary of the thromboprophylaxis survey in Danish surgical departments
• Evidence of publication bias for antidepressant drugs.
• Evidence of uncertainty: an assessment of how many Cochrane Clinical Answers provide a clear confident Answer to the question posed
• Evidence of uncertainty: an assessment of how many Cochrane Clinical Answers provide a clear confident answer to the question posed